All Stories

Recursion lays off 20% of staff in wake of pipeline cutbacks

Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline.

Jun 10, 2025 - 15:00
 0
Recursion lays off 20% of staff in wake of pipeline cutbacks
Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline.
Read More

Tags:

Previous Article

Pfizer CEO talks Chinese due diligence, ADC synergies to justify $6B bet on ‘fab...

Next Article

National Resilience, a well-funded manufacturing startup, to scale back operations

Related Posts

ASCO: Ernexa's 'Trojan Horse' stem cell therapy shrinks ovarian tumors in mice

ASCO: Ernexa's 'Trojan Horse' stem cell therapy shrinks...

Jun 2, 2025  0

Endometrial cancer data on Genmab's Elahere rival beat forecast, fueling push into phase 3

Endometrial cancer data on Genmab's Elahere rival beat ...

May 27, 2025  0

J&J study examines Shockwave-first strategy in women with blocked coronary arteries

J&J study examines Shockwave-first strategy in women wi...

May 20, 2025  0